Focus on organic and external growth
Specialty chemicals group Lanxess is announcing a new mid-term goal for its leading earnings indicator – EBITDA pre exceptionals – of €1.8bn in 2018. The company says it is strategically well positioned to continue on its established growth path and plans to achieve its established growth path and plans to achieve its previously established goal of €1.4bn EBITDA pre exceptionals in 2014, a year ahead of schedule. Lanxess has increased its key performance indicator by an average of 20% annually since 2004.
The focus for the company remains on emerging high growth markets and this will remain essential to Lanxess’ long-term growth. Since 2005 the company has grown by nearly 70% in the Asia-Pacific region and by almost 40% in North America and Latin America combined.
Axel C Heitmann, chairman of the board of management of Lanxess comments: “We have transformed Lanxess into a growth company. In order to achieve our new mid-term goal we will stick to our proven dual-track strategy of organic and external growth.”